Clinical Trial Detail

NCT ID NCT01827384
Title Molecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Adavosertib + Carboplatin

Temozolomide + Veliparib

Everolimus

Trametinib

Age Groups: adult

No variant requirements are available.